|
Volumn 19, Issue 2, 2013, Pages 165-172
|
Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.
a b b b b b b b b b b b b b b b b b b b more..
b
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ANTIVIRUS AGENT;
CARNITINE;
ENTECAVIR;
GAMMA INTERFERON;
GUANINE;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
VIRUS DNA;
VITAMIN B COMPLEX;
ADULT;
ANALOGS AND DERIVATIVES;
BLOOD;
CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
ENZYME LINKED IMMUNOSPOT ASSAY;
FEMALE;
GENETICS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
MITOCHONDRION;
MULTICENTER STUDY;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADULT;
ALANINE TRANSAMINASE;
ANTIVIRAL AGENTS;
CARNITINE;
DNA, VIRAL;
DRUG THERAPY, COMBINATION;
ENZYME-LINKED IMMUNOSPOT ASSAY;
FEMALE;
GUANINE;
HEPATITIS B E ANTIGENS;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
INTERFERON-GAMMA;
MALE;
MIDDLE AGED;
MITOCHONDRIA;
TREATMENT OUTCOME;
VITAMIN B COMPLEX;
|
EID: 84892748235
PISSN: None
EISSN: 2287285X
Source Type: Journal
DOI: 10.3350/cmh.2013.19.2.165 Document Type: Article |
Times cited : (23)
|
References (0)
|